2012 annual financial data
Supernus Pharmaceuticals 2012 Operating margin
Direct answer
Operating margin was -2,849.26%.
Operating income was -42,169,000 USD and net income was -46,284,000 USD.
Operating cash flow was -47,199,000 USD.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,480,000 USD
- Operating income
- -42,169,000 USD
- Net income
- -46,284,000 USD
- Operating cash flow
- -47,199,000 USD